Tags: Monoclonal AntibodiesCancerAntibody ResearchBispecific AntibodiesDLBCL Trials
| Profile | Contacts | Recent Articles on Subject | |
|---|---|---|---|
| 1 | Amir Ali, PharmD, BCOP Pharmacy Times Clinical Hem/Onc Pharmacist. USC Assistant Professor. Founder of OncologySolutionsRx. Los Angeles, CA | ||
| 2 | Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. | STAT+: For a leukemia that keeps returning, AbbVie drug may offer chance for a deep remission - about 1 month ago Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago | |
| 3 | Jonathan Wosen STAT News West Coast Biotech Reporter. Formerly @sdut. Stanford PhD. UCSC alum. San Diego, California | Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago Sanofi advances a drug for a rare, platelet-destroying disease - about 1 month ago | |
| 4 | Meghana Keshavan STAT News Biotech nerd and writer @statnews. | Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago | |
| 5 | Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts | Biopharma leaders lay out vision for the future of blood cancer treatment - about 1 month ago Sanofi advances a drug for a rare, platelet-destroying disease - about 1 month ago | |
| 6 | Ryan Haumschild, PharmD, MS, MBA Pharmacy Times Director of Pharmacy. Editorial Board member. Atlanta, Georgia | Current Landscape of Bispecific Therapies for RRMM - about 2 months ago | |
| 7 | Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - about 2 months ago | |
| 8 | John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. | Novel Anti-IgG Drug Hits Mark in Sjogren's Patients - about 2 months ago | |
| 9 | Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA | ||
| 10 | Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey | Advances in CAR T-Cell Therapy and Bispecifics for Relapsed/Refractory Multiple Myeloma - 3 months ago |